- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 24th, 2007
ANALYSIS: Drugmakers Set High Hopes On Nanotech-Based DDS Drugs
The prolonged absence of new drugs on the market reflects the rush by overseas and domestic drugmakers to develop DDS (drug delivery system) technology that uses nanotechnology to deliver existing cancer drugs to patients in capsule form.
On Jan. 4, the Ministry of Health finally approved a cancer treatment that has been available abroad for 12 years. Authorized for the first time here as a treatment for AIDS-related Kaposi's sarcoma, Doxil, a niche drug developed by Janssen Pharmaceutical KK, marks the beginning of nanotech-based DDS drugs in Japan.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Yale researchers’ technology turns wasted heat into power June 27th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016